Subjects with T2D were treated with diet or diet plus metformin and/or sulfonylureas and were taking no other medicines for their T2D
because of the potential effects of other diabetes medicines on endothelial function, cardiac function, and exercise capacity.
Persons with T2D were accepted for the study only if they had total HbA1C levels